DNA-alkylating anti-FRalpha antibody-drug conjugate (Immunogen)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameDNA-alkylating anti-FRalpha antibody-drug conjugate (Immunogen)
Drug Alias NameDNA alkylating effector molecules (Immunogen)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionFolate receptor alpha antagonists
TargetsFolate receptor alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunogen Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A